ArticleChemistry & biodiversity2026
Computational Approach to Select Lead-Like Compounds From an Opioid Class of Novel Psychoactive Substances.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The continuous emergence of novel psychoactive substances (NPS) poses significant challenges to drug discovery, regulation, and public health. In this study, a computational chemometric approach was applied to evaluate 134 opioids belonging to the NPS class using ACD/Percepta software. Parameters that were predicted are physicochemical characteristics, ADME (Absorption, Distribution, Metabolism, and Excretion) profiles, and toxicity endpoints. Data pre-processing involved standardization, outlier detection via Grubbs' test, and distribution assessment using the Kolmogorov-Smirnov test. Multivariate statistical analyses (MANOVA, discriminant analysis, and principal component analysis) revealed significant correlations between Lipinski and lead-likeness violations and parameters such as log P, molecular weight, solubility, protein binding, blood-brain barrier penetration, metabolic stability, P-glycoprotein interaction, and cytochrome P450 inhibition. Discriminant analysis achieved up to 100% classification accuracy for certain parameter combinations, suggesting that log P and molecular weight alone can reliably predict broader ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiles. These results demonstrate the utility of integrating in silico prediction platforms with chemometric methods to prioritize candidate compounds for further experimental evaluation, thereby supporting efficient lead selection within the opioid NPS class.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.